• Jan 12, 2018
    As a reminder to all IPC stores, you have until the close of business Tuesday, January 16, 2018 to submit your comments to The Centers for Medicare & Medicaid Services (CMS) supporting its proposed rule that ends the retroactive DIR fees by requiring the PBMs to apply all pharmacy price concessions, including DIR fees, to the price of the drug at the point of sale.
  • Nov 20, 2017
    The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes a number of changes that, if finalized, will ensure that Part D Medicare enrollees have access to more affordable prescription drugs and more robust prescription drug coverage at the pharmacy they prefer. The rule also gives health plans a new tool to combat the opioid crisis.
  • Nov 17, 2017
    Though Amazon’s pharmacy involvement could presumably disrupt both business-to-business and business-to-consumer sectors of the pharmaceutical supply chain, it is most likely to initially enter into the medical device or cash prescription business. It was disclosed this week that in at least two of the states that Amazon had applied for wholesale drug/device distribution licenses that the company didn’t intend on selling prescription drugs.
  • Nov 16, 2017
    U.S. Senate Democratic Whip Dick Durbin (D-IL) today previewed new legislation that will empower patients and promote transparency by requiring the pharmaceutical industry to provide more information about the cost of drugs in their advertisements.
  • Jul 21, 2017
    While the prospect of repealing and replacing the Affordable Care Act remains uncertain in Congress, there are other federal legislative activities that impact pharmacy that IPC has been actively engaged in, especially as it relates to drug price increases and the role of PBM’s.
  • Jul 17, 2017
    The Pharmacy and Medically Underserved Areas Enhancement Act of 2017 introduced as S.109 and H.R. 592 continues to be a priority for IPC’s advocacy team. The legislation would allow pharmacists to bill for Medicare Part B services and would enhance access to healthcare in many areas of the country. IPC has met with numerous Congressional members to express support for this much needed change in reimbursement for pharmacy provided services.